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Vascular malformations: 
a review of 10 years' management in a university hospital
I
Abstract In order to gain insight into the management of 
patients with vascular malformations (VM) in the Univer­
sity Hospital Nijmegen in the past 10 years, 151 cases 
managed by different specialists were reviewed. To avoid 
the usual confusion in terminology, all recorded diagnoses 
were reclassified according to the biological classification 
of Mulliken. The sex distribution was equal; 79% of the 
malformations were diagnosed at birth or in the 1 st year of
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life. The median time between presentation and consulta­
tion was 3 years. Sixty-two lymphatic, 26 venous, 24 
capillary, 1 arterial, and 38 combined malformations (8 
arteriovenous, 30 others) were found. The head and neck 
region was most frequently involved, followed by the lower 
and upper limbs and trunk. The pediatric surgeon was the 
most frequently consulted specialist. Confusing, mutually 
incompatible terminology and a wide variety of different 
diagnostic techniques and treatments had been used by the 
different specialists. To improve the management of pa­
tients with vascular malformations, the use of a uniform 
classification, an increase in basic investigations, and the 
development and evaluation of protocols for diagnosis and 
treatment by multidisciplinary teams are necessary.
Key words Vascular malformations • Blood vessels • 
Angioma • Congenital
Introduction
In the preface to their book, Mulliken and Young described 
the difficulties encountered by patients with vascular birth­
marks in trying to find a doctor who is able to understand 
and reassure them, so they can stop “shopping around” in 
the medical community [8]. Confusing nomenclature has 
always been an obstacle in the management of vascular 
lesions. To the despair of patients and their parents, con­
sulted specialists use different terminologies and propose 
different diagnostic and therapeutic regimes.
In 1982, Mulliken and Glowacki introduced a biological 
classification for vascular lesions [71. Based on cellular 
investigations and clinical observations, these lesions are 
classified as either hemangiomas, characterized by endo­
thelial hyperplasia, or vascular malformations (VM), struc­
tural abnormalities due to errors in vascular morphogenesis. 
Hemangiomas show rapid postnatal growth followed by 
slow involution. Eponyms are no longer necessary because 
they have no relevance for describing the clinical bahavior 
of the lesions. VMs, however, are present at birth, grow
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Table 1 Reclassification of old nomenclature into Mulliken1 s biolo­
gical classification
investigations that had been performed and, finally, all treatment 
modalities used were noted.
Old terminology Biological classification
Capillary hemangioma \
Capillary-venous hemangioma —» 
Cherry angioma /
Hemangioma
Port-wine stain 
Teleangiectatic anomalies
Arterial abnormality
Cavernous hemangioma 
Venous abnormality 
Bockenheimer syndrome
Lymphangioma 
Cystic hygroma
Single malformation 
Capillary malformation
/
Arterial malformation
\
/
Venous malformation
Lymphatic malformation
/
Arteriovenous abnormality 
Rlippel-Trenaunay syndrome
Parkes Weber syndrome
Sturge Weber syndrome
Combined malformation 
Arteriovenous malformation 
Capillary-venous-lymphatic 
Malformation
Capillary-arteriovenous-lymphatic
Malformation
combined malformation
commensurately with the child, and never regress sponta­
neously. They can be arterial, capillary, venous, lymphatic, 
or show any combinations of these components* In this 
study, the word hemangioma is thus restricted to a specific 
vascular lesion of childhood and is no longer used as a 
denominator for all kinds of different vascular lesions.
In order to gain insight into the management of patients 
with VMs, a retrospective study was carried out on all such 
patients treated in the University Hospital Nijmegen in the 
past 10  years.
Materials and methods
Using the hospital's computerized STARDO coding system, we gen­
erated a list of patients who had been seen and/or treated for a vascular 
lesion in the departments of dermatology, pediatrics, pediatric surgery, 
otolaryngology, orthopedics, plastic and reconstructive surgery, vascu­
lar surgery, and craniofacial surgery in the period 1983-1994. The 
search criteria included the following diagnosis: hemangioma, lym­
phangioma, congenital malformation of the peripheral vascular system, 
vascular hamartoma, and hamartosis. In the department of orthopedics, 
the search for patients who had been treated for vascular tumors was 
carried out through a special “tumor archive.” In the department for 
non-invasive vascular investigations a list of patients who had been 
investigated for the Klippel-Trenaunay syndrome was available.
Although no uniform classification system for vascular lesions had 
been used during the reviewed period, we decided to use the biological 
classification of Mulliken in this study to obtain a better perspective of 
the different vascular lesions. After studying the records of the patients 
and, if available, the pathology reports, the original diagnosis was 
reclassified according to the Mulliken classification with the help of 
Table 1. In this way, hemangiomas were separated from VMs and 
excluded from the study. The VMs were subdivided into arterial, 
capillary (CM), lymphatic (LM), venous (VeM), and combined mal­
formations. Furthermore, the age at presentation, the time between the 
first observation and first consultation of a specialist at this hospital, 
the kind of specialist who had been consulted, and the affected body 
part were recorded. All records were screened for the extra diagnostic
Results
From the 450 records initially found under the search 
criteria hemangioma, lymphangioma, congenital malforma­
tion of the peripheral vascular system, vascular hamartoma, 
and hamartosis, 151 patients (79 women, 72 men) had a 
VM according to the biological classification of Mulliken. 
The median age at presentation was 1 month; 19%  of all 
VMs were noticed at birth or during the 1st year of life. The 
median time that passed between the first observation of the 
VM and the first consultation of a specialist at this hospital 
was 3 years (0-68 years).
In Table 2, the original and revised diagnoses according 
to the biological classification are shown. In 17 patients 
with a recorded diagnosis of hemangioma the biological 
diagnosis appeared to be a VeM (16) or arteriovenous (1) 
malformation (AVM). Most lymphangiomas, hemangio- 
lymphangiomas, and cystic hygromas were translated into 
LMs except in 4 cases, which were reclassified as VMs or 
venous-lymphatic malformations. A wide variety of names 
(Table 2) was used to desribe CMs. We classified the 
Rendu-Osler syndrome as a CM. The two patients with 
Bockenheimer syndrome appeared to have predominantly 
venous anomalies, and were renamed as VeMs. The original 
record diagnoses of AVMs complied with the revised 
diagnoses, while 1 hemangioma turned out to be an 
AVM. The Klippel-Trenaunay syndrome (port-wine stain, 
venous lesions, and hypertrophy) was translated into a 
combined malformation or, more specifically, capillary- 
venous-lymphatic malformation. The other combined mal­
formations (8) were originally diagnosed as Parkes-Weber 
syndrome (4) (port-wine stain, multiple AV fistulae, and 
hypertrophy) or Sturge-Weber syndrome (4) (port-wine 
stain of the face and vascular lesions of leptomeningeal 
vessels leading to neurological problems).
The head and neck region was affected in 75 patients 
(face 35, neck 32, oropharynx 8), the lower limb in 62, the 
upper limb in 18, and the trunk in 15. (Note: since in 17 
patients two or more body parts were involved, the total 
number of affected body parts is more than 151.) The 
pediatric surgeon was the most frequently consulted spe­
cialist, followed by the dermatologist, orthopedist, and 
plastic surgeon. Thirty patients (20%) consulted two or 
more specialists. Table 3 shows the consulted specialists in 
relation to the different kinds of VMs.
Forty-eight patients did not undergo additional diagnos­
tic investigations. The majority were diagnosed as having a 
LM (22) or CM (20). No further diagnostic investigations 
were done in 5 patients with a combined malformation and
1 with a VeM. Of the 103 patients who underwent extra 
diagnostic procedures, 68 were subjected to two or more 
investigations. The total number of diagnostic procedures 
was 191. Table 4 shows which non-invasive and invasive 
diagnostic procedures were applied in relation to the
298
Table 2 Original and revised diagnoses (art arterial, cap capillary, lymph lymphatic, ven venous)
Original diagnosis
Lymphangioma 
Klippel-Trenaunay syndrome 
Hemangioma 
Port-wine stain 
Cystic hygroma 
Arteriovenous malformation 
Parke s-Weber syndrome 
Sturge-Weber syndrome 
Venous anomaly 
Angioma serpiginosum 
Bockenheimer syndrome 
Hemangiolymphangioma 
Nevus vascularis 
Couperosis
Granuloma telangiectatica 
Hypoplastic vascular system 
Nevus teiangiectaticus 
Rendu-Osler syndrome
Total
Diagnosis according to biological classification
Single
1
1
16
Combined
Art Cap Lymph Ven Art-ven Ven-lymph Cap-ven-lymph Cap-art-ven-lymph Other
45
15
2
2
1
1
1
1
24 62
3
1
16 1
4
2
7
26 8
1
21
4
4
1 21 4 4
Total
49
22
17
16
15
7
4
4
4
2
2
2
2
1
1
1
1
1
151
Table 3 Consulted specialists for different vascular malformations (Total >151 because of multidisciplinary treatment in 30 patients)
Specialist Vascular malformation
Single Combined
Total
Art Cap Lymph Ven Art-ven Ven-lymph Cap-ven-lymph Cap-art-ven-lymph Other
Pediatric surgeon 1 2 58 8 3 — 2 — 74
Dermatologist — 20 1 4 1 — 20 4 M M * 50
Orthopedic surgeon 1 — 1 13 2 — 2 — --------- 19
Plastic surgeon 1 2 11 2 — 1 — — --------- 17
Pediatrician — 3 3 2 1 — 1 — 3 13
Otolaryngologist — 5 — 3 — — — 8
Craniofacial surgeon — — 2 — 1 — — — 1 4
Vascular surgeon — — — — 1 — — 2 — 3
Table 4 Diagnostic techniques (Total >151 because of multiple procedures in 68 patients. US ultrasound, ED  echo-Doppler, X  plain X-ray, CT  
computed tomography, M R I  magnetic resonance imaging, SCIN  scintigraphy, DSA  digital subtraction angiography, PHL phlebography, END 
endoscopy, BIOP  biopsy)
Malformation Diagnostic technique ' Total
Non-invasive Invasive
US ED X CT MRI SCIN DSA PHL END BIOP
Single
Arterial 1 1 2
Capillary 1 1 1 1 — — 1 — 1 1 7
Lymphatic 17 2 24 3 4 1 1 — 1 3 56
Venous 4 7 18 7 9 5 13 1 2 2 68
Combined
Arterio-venous 2 4 3 2 2 6 1 3 23
Other 1 22 5 — — 5 2 — MM» 35
Total 23 35 52 14 15 8 27 4 4 9 191
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Table 5 Treatment modalities (Total >151 because of multiple procedures in 21 patients. Corticost corticosteroids, ctyo  cryotherapy, emboli 
embolization)
Malformation Treatment Tota]
»
None Non-invasive Invasive •
Compression Corticost Laser Cryo Sclerotherapy OK432 Emboli Excision Amputation
Single
Arterial 1 1
Capillary 10 1 10 — — — 1 2 24
Lymphatic 11 1 — — — 1 — 49 w- 62
Venous 3 2 2 1 — — — — 19 — 27
Combined 
Arterio-venous 1 1 1 3 5 11
Combined other 11 15 2 1
«• 3 3 2 37
Total 36 19 2 13 2 1 1 7 79 2 162
different VMs. Retrospectively, it was impossible to deter­
mine whether diagnostic procedures were used to come to a 
final diagnosis or whether they were performed to obtain 
preoperative information about anatomic borders of the 
lesion or underlying anomalies.
In 36 patients no treatment was used; in the other 115 
one or more methods were employed. Table 5 shows the 
distribution of the different VMs and the various non- 
invasive (36) and invasive (90) treatments used. Two 
patients with the reclassified diagnosis of a VeM were 
treated with corticosteroids, presumably because their le­
sions were considered to be hemangiomas. Compression 
garments were mainly used in patients with combined or 
VeMs, whereas laser therapy was performed for the treat­
ment of CMs. In 1 patient with a LM OK 432 was injected 
into the lesion [9]. Embolization was primarily used for the 
treatment of AVMs and combined malformations. Since the 
majority of malformations were lymphatic or venous and 
since the main treatment for these malformations was 
excision, excision was by far the most employed treatment.
Discussion
Confusing terminology has always been an obstacle in the 
management of patients with vascular lesions. The word 
hemangioma is used by pathologists and clinicians to 
describe a variety of VMs of different etiologies. Mulliken 
and Glowacki proposed a biological classification for 
vascular lesions based on both cellular and clinical studies 
[7]. In this useful classification, the word hemangioma is 
reserved to describe a rapidly growing vascular tumor of 
childhood that is characterized by endothelial hyperplasia. 
All other vascular lesions caused by errors in vascular 
morphogenesis are called malformations. Dependent on 
the kind of abnormal vascular structure, the malformations 
are subdivided into arterial, capillary, lymphatic, venous, or 
combined malformations. VMs have a relatively low in­
cidence, and the different types of malformation are treated 
by various specialists.
In this study, we tried to obtain uniformity in the 
nomenclature by reclassification of the originally recorded 
diagnoses. In this way, only 151 true VMs could be selected 
out of 450 patients with a vascular lesion. The remainder 
consisted of hemangiomas (according to the biological 
classification) and some non-vascular lesions. The results 
concerning sex distribution, affected body part, and presen­
tation of the selected group of VMs proved to be in 
correspondence with other reports on this subject [1-3 , 5, 
6], VMs were diagnosed in male and female patients in an 
almost equal distribution (72:79). The head and neck 
region was most frequently affected, followed in decreasing 
order by the lower and upper limbs and trunk. A majority of 
the VMs (79%) had already been noticed at birth or during 
the 1st year of life, We did not find a second incidence 
peak, which has been described to occur around puberty or 
pregnancy due to enlargement of the still-undiscovered 
malformation from hormonal changes [3, 11]*
The delay between manifestation of the VM and con­
sultation of a specialist (median: 3 years) can be partly 
explained by the fact that some patients consulted other 
specialists before they were referred to this hospital. Some 
visited this hospital on their own initiative after failure of 
treatment elsewhere. No complete data were available on 
these prior treatments. On the other hand, this delay 
indicates that VMs can exist for a period of time without 
causing problems that require medical attention [3, 11]. The 
number and distribution of VMs shown in Table 2 should 
not be considered to be the incidence of VMs in the normal 
population. Since not all VMs require medical attention and 
not all patients with VMs were sent to this hospital, the 
figures in Table 2 merely demonstrate the kinds and 
numbers of VMs that were treated in this hospital.
A wide variety of non-invasive and invasive diagnostic 
techniques has been used for investigation of the different 
VMs. Echo-Doppler and magnetic resonance imaging/an­
giography have played an increasing role in the diagnostic 
work-up of vascular lesions during the past few years [3, 4]. 
However, their exact position in the work-up of VMs still 
has to be determined. In our opinion, invasive diagnostic 
techniques like angiography should only be used if relevant
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information for diagnosis, prognosis, or further treatment 
can be obtained or if embolization is considered the most 
appropriate therapy for a particular malformation.
During the past 10 years excision has been the most 
frequently used treatment for VMs in this hospital. This is 
primarily due to the predominance of LMs, for which 
excision is an established treatment modality. In contrast, 
sclerotherapy, and embolization have only occasionally 
been employed. These techniques have, however, been 
applied more successfully for special forms of VMs during 
the past 10 years [10]. In this study no data were collected 
on postoperative complications, recurrence rates, and the 
patient’s and clinician’s satisfaction with the result of the 
treatment. Perhaps a more conservative approach to some 
malformations or more agressive treatment of others is 
indicated, but this can only by proven by new investigations 
in which the management of patients with VMs according 
to previously determined protocols is prospectively evalu­
ated.
To avoid the problems of confusing terminology and 
interdisciplinary differences in management in the future, 
we believe a team approach to most VMs will be beneficial. 
Various specialists, all using the same nomenclature, have 
to share their experience in this difficult area of vascular 
pathology to arrive at a rational diagnostic strategy and 
treatment plan for VMs. Furthermore, standardized proto­
cols for diagnosis and treatment with long-term follow-up 
should be developed in national and international organiza­
tions like those in oncology. Basic research in pathology 
and embryology in order to understand the underlying 
causes of VMs, which could have implications for new 
treatments and even prevention in the future, is essential. 
Because VMs have a relatively low incidence, cooperation 
between national and international multidisciplinary teams 
is desirable [1 , 6].
We conclude that the presentation of VMs in the Uni­
versity Hospital Nijmegen during the past 10 years has been 
in accordance with other reports in the literature. We also 
found that a large gamut of confusing terminology as well 
as a wide range of diagnostic and treatment modalities had 
been used by the different specialists. In order to improve
the management of patients with VMs, the use of a uniform 
classification should be encouraged, basic research has to 
be stimulated, and standardized protocols for diagnosis and 
treatment have to be developed and evaluated. National and 
international cooperation in this field must be promoted. 
The formation of multidisciplinary teams in which, due to 
the age at presentation of most VMs, a pediatrician and 
pediatric surgeon are represented, seems to be a prerequisite 
to achieve these goals.
References
1. Belov ST, Loose DA, Weber J (1989) Vascular malformations. 
Einhorn, Reinbek
2. Enjolras O, Herbretau D, Lemarchand F (1992) Hémangiomes et 
malformations vasculaires superficielles: classification. J Malad 
Vase 17: 2 -1 9
3. Enjolras O, Riche MC, Merland JJ (1991) Malformations vascu­
laires superficielles (artérielles et veineuses): aspects cliniques et 
examens complémentaire. Ann Chir Plast Esthét 36: 27 3 —278
4. Herbretau D, Enjolras O, Lemarchand F (1992) Stratégie d’ex­
ploration des malformations vasculaires superficielles. J Malad 
Vase 17: 2 6 -3 2
5. Jackson IT, Carreno R, Potparic Z, Hussain K (1993) Hemangio­
mas, vascular malformations and lymphovenous malformations: 
classification and methods of treatment. Plast Reconstr Surg 91: 
1216-1230
6. Kromhout JG (1991) Vascular malformations of the extremities: 
historical review of classification and patient follow-up study. 
Thesis, University of Amsterdam
7. Mulliken JB, Glowacki J (1982) Hemangiomas and vascular 
malformations in infants and children: a classification based on 
endothelial characteristics. Plast Reconstr Surg 69: 412-420
8. Mulliken JB, Young AE (1988) Vascular birthmarks: hemangio­
mas and vascular malformations. Saunders, Philadelphia
9. Ogita S, Tsuto T, Deguchi E, Tokiwa K, Nagashima N, Iwai N 
(1991) OK-432 therapy for unresectable lymphangiomas in chil­
dren. J Pediatr Surg 26: 263-270
10. Riché MC, Merland JJ (1988) Embolization of vascular malforma­
tions. In: Mulliken JB, Young AE (eds) Vascular birthmarks: 
hemangiomas and vascular malformations. Saunders, Philadelphia, 
pp 436-453
11. Young AE (1988) Pathogenesis of vascular malformations. In: 
Mulliken JB, Young AE (eds) Vascular birthmarks: hemangiomas 
and vascular malformations. Saunders, Philadelphia, pp 107-113
